NAD(P)H Dehydrogenase (Quinone)

"NAD(P)H Dehydrogenase (Quinone)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A flavoprotein that reversibly catalyzes the oxidation of NADH or NADPH by various quinones and oxidation-reduction dyes. The enzyme is inhibited by dicoumarol, capsaicin, and caffeine.

Descriptor ID	D016660
MeSH Number(s)	D08.811.682.608.800.500
Concept/Terms	NAD(P)H Dehydrogenase (Quinone) NAD(P)H Dehydrogenase (Quinone) Quinone Reductase Reductase, Quinone Phylloquinone Reductase Reductase, Phylloquinone DT Diaphorase Diaphorase, DT Menadione Reductase Reductase, Menadione Vitamin K Reductase Vitamin K Reductase Reductase, Vitamin K

Below are MeSH descriptors whose meaning is more general than "NAD(P)H Dehydrogenase (Quinone)".

Chemicals and Drugs [D]
Enzymes and Coenzymes [D08]
Enzymes [D08.811]
Oxidoreductases [D08.811.682]
NADH, NADPH Oxidoreductases [D08.811.682.608]
Quinone Reductases [D08.811.682.608.800]
NAD(P)H Dehydrogenase (Quinone) [D08.811.682.608.800.500]

Below are MeSH descriptors whose meaning is related to "NAD(P)H Dehydrogenase (Quinone)".

Below are MeSH descriptors whose meaning is more specific than "NAD(P)H Dehydrogenase (Quinone)".

NAD(P)H Dehydrogenase (Quinone)
zeta-Crystallins

publications

Timeline | Most Recent

This graph shows the total number of publications written about "NAD(P)H Dehydrogenase (Quinone)" by people in this website by year, and whether "NAD(P)H Dehydrogenase (Quinone)" was a major or minor topic of these publications.

Bar chart showing 41 publications over 15 distinct years, with a maximum of 9 publications in 2003

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	1	0	1
1999	1	0	1
2002	1	3	4
2003	4	5	9
2004	2	1	3
2006	1	2	3
2007	0	1	1
2009	0	1	1
2010	1	5	6
2011	0	2	2
2012	1	1	2
2014	0	1	1
2016	1	1	2
2017	1	2	3
2018	1	1	2

Below are the most recent publications written about "NAD(P)H Dehydrogenase (Quinone)" by people in Profiles.

Zhang M, Park EJ, Kondratyuk TP, Pezzuto JM, Sun D. Synthesis and Structure-Activity Relationships of Tetrahydro-?-carboline Derivatives as Anticancer and Cancer-chemopreventive Agents. Anticancer Res. 2018 Aug; 38(8):4425-4433.

View in: PubMed
da Silva ES, Oliveira BG, Pereira ACH, Pimentel EF, Pezzuto JM, Lenz D, Kondratyuk TP, Andrade TU, Fronza M, Scherer R, Maia JF, Rom?o W, Alves FL, Ventura JA, Endringer DC. Induction of NAD (P)H: Quinone reductase 1 (QR1) and antioxidant activities in vitro of 'Toranja Burarama' (Citrus maxima [Burm.] Merr.). Phytother Res. 2018 Oct; 32(10):2059-2068.

View in: PubMed
Chang SY, Weber EJ, Sidorenko VS, Chapron A, Yeung CK, Gao C, Mao Q, Shen D, Wang J, Rosenquist TA, Dickman KG, Neumann T, Grollman AP, Kelly EJ, Himmelfarb J, Eaton DL. Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. JCI Insight. 2017 11 16; 2(22).

View in: PubMed
Prior AM, Yu X, Park EJ, Kondratyuk TP, Lin Y, Pezzuto JM, Sun D. Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1. Bioorg Med Chem Lett. 2017 12 15; 27(24):5393-5399.

View in: PubMed
Yonchuk JG, Foley JP, Bolognese BJ, Logan G, Wixted WE, Kou JP, Chalupowicz DG, Feldser HG, Sanchez Y, Nie H, Callahan JF, Kerns JK, Podolin PL. Characterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative Stress. J Pharmacol Exp Ther. 2017 10; 363(1):114-125.

View in: PubMed
Youn UJ, Park EJ, Kondratyuk TP, Sang-Ngern M, Wall MM, Wei Y, Pezzuto JM, Chang LC. Anti-inflammatory and Quinone Reductase Inducing Compounds from Fermented Noni (Morinda citrifolia) Juice Exudates. J Nat Prod. 2016 06 24; 79(6):1508-13.

View in: PubMed
Fatima N, Kondratyuk TP, Park EJ, Marler LE, Jadoon M, Qazi MA, Mehboob Mirza H, Khan I, Atiq N, Chang LC, Ahmed S, Pezzuto JM. Endophytic fungi associated with Taxus fuana (West Himalayan Yew) of Pakistan: potential bio-resources for cancer chemopreventive agents. Pharm Biol. 2016 Nov; 54(11):2547-2554.

View in: PubMed
Parrish SM, Yoshida WY, Kondratyuk TP, Park EJ, Pezzuto JM, Kelly M, Williams PG. Spongiapyridine and related spongians isolated from an Indonesian Spongia sp. J Nat Prod. 2014 Jul 25; 77(7):1644-9.

View in: PubMed
Mayhoub AS, Marler L, Kondratyuk TP, Park EJ, Pezzuto JM, Cushman M. Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1). Bioorg Med Chem. 2012 Dec 15; 20(24):7030-9.

View in: PubMed
Luqman S, Meena A, Singh P, Kondratyuk TP, Marler LE, Pezzuto JM, Negi AS. Neoflavonoids and tetrahydroquinolones as possible cancer chemopreventive agents. Chem Biol Drug Des. 2012 Oct; 80(4):616-24.

View in: PubMed

People

Explore

Similar Concepts

Top Journals